A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
The startup raised $30 million from Booz Allen Hamilton Ventures, NordicNinja and others.
The controversial enforcement actions have been called a “cash cow” by Commissioner Hester Peirce.
Wall Street ended 2024 on a high note, providing investors with a sigh of relief as we enter the new year.